eMalick Njie

eMalcik Njie

Ecotone AI

eMalick Njie is the CEO and Founder of Ecotone AI, a company with a vision of AI-designed medicines to cure rare inherited diseases. eMalick is also co-founder of Genetic Leap, formerly known as Genetic Intelligence, a company that is innovating at the cutting edge of AI and RNA genetic medicine to redefine drug development and more quickly address the health needs of millions of people.

Before his transition into entrepreneurship and industry, he was a Senior Scientist at Columbia University, where he discovered multiple C. elegans genes related to neural ensheathment and sensation of touch in the laboratory of Nobel prize winner Martin Chalfie.

eMalick Njie, Ph.D | Part 4: How Ecotone AI Is Revolutionizing Genomics & Rare Disease Treatment

Building Ecotone AI to Cure Rare Diseases | Diffusion Transformers in Genomics | Synthetic Genomes for AI Training | Long-Term Vision for Genetic Breakthroughs

eMalick Njie, Ph.D | Part 3: Shaping the Future of Genetics Research with AI

Founding an AI-Powered Biotech | Overcoming Challenges & Personal Sacrifices | Importance of Team Alignment | Combining AI, Genetics, & Population Studies

eMalick Njie, Ph.D | Part 2: Answering the Question “What is Memory?”

What is Memory? | Playing “Stump the Professor” | Lab Coat Labs vs Sandals Labs | Wanting to Help People at Scale

Keep Up with The Biotech Startups Podcast

Start listening to TBSP episodes on your favorite platform.  Subscribe to stay up to date on new episodes.

A hand holding a bell